SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,367,379 | -34.4% | 353,328 | +1.0% | 0.02% | -36.0% |
| Q2 2023 | $2,086,000 | -8.9% | 350,000 | -50.0% | 0.02% | -19.4% |
| Q1 2023 | $2,289,000 | -7.0% | 700,000 | +12.3% | 0.03% | -6.1% |
| Q4 2022 | $2,461,901 | -66.3% | 623,266 | -48.8% | 0.03% | -67.6% |
| Q3 2022 | $7,301,000 | -14.2% | 1,216,916 | -8.0% | 0.10% | -22.1% |
| Q2 2022 | $8,508,000 | -33.6% | 1,323,233 | -14.7% | 0.13% | -37.0% |
| Q1 2022 | $12,819,000 | +71.6% | 1,551,940 | +221.5% | 0.21% | +94.4% |
| Q4 2021 | $7,472,000 | -21.0% | 482,706 | +15.0% | 0.11% | -30.5% |
| Q3 2021 | $9,455,000 | +17.1% | 419,867 | +2.2% | 0.15% | +2.0% |
| Q2 2021 | $8,077,000 | -40.0% | 410,848 | +2.2% | 0.15% | -49.3% |
| Q1 2021 | $13,455,000 | – | 401,994 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |